The whole world of gambling is on your smartphone with the Mostbet app - join us!
Home  »  Business   »  Cronos Group Inc. (CRON) Stock Faces 10.81% Weekly...

Cronos Group Inc. (CRON) Stock Faces 10.81% Weekly Volatility

The stock of Cronos Group Inc. (CRON) has gone down by -1.46% for the week, with a 24.47% rise in the past month and a 38.30% rise in the past quarter. The volatility ratio for the week is 10.81%, and the volatility levels for the past 30 days are 8.11% for CRON. The simple moving average for the past 20 days is 17.66% for CRON’s stock, with a 12.60% simple moving average for the past 200 days.

Is It Worth Investing in Cronos Group Inc. (NASDAQ: CRON) Right Now?

while the 36-month beta value is 1.39.Analysts have differing opinions on the stock, with 3 analysts rating it as a “buy,” 1 as “overweight,” 5 as “hold,” and 0 as “sell.”

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


The average price point forecasted by analysts for Cronos Group Inc. (CRON) is $2.44, which is $1.21 above the current market price. The public float for CRON is 199.95M, and currently, short sellers hold a 5.17% ratio of that floaft. The average trading volume of CRON on September 18, 2023 was 2.56M shares.

CRON) stock’s latest price update

The stock price of Cronos Group Inc. (NASDAQ: CRON) has plunged by -1.05 when compared to previous closing price of 2.39, but the company has seen a -1.46% decline in its stock price over the last five trading sessions. Market Watch reported 2023-09-18 that The U.S.-listed shares of Cronos Group Inc. CRON, -3.24% CRON, -3.56% climbed 2.5% in premarket trading Monday, after the Toronto-based cannabis company said it launched its Peace Naturals medical brand in Germany. The company has signed a distribution agreement with Cansativa Group, which has a network of about 2,000 pharmacies in Germany.

Analysts’ Opinion of CRON

Many brokerage firms have already submitted their reports for CRON stocks, with Bernstein repeating the rating for CRON by listing it as a “Mkt Perform.” The predicted price for CRON in the upcoming period, according to Bernstein is $3 based on the research report published on November 02, 2022 of the previous year 2022.

CRON Trading at 23.13% from the 50-Day Moving Average

After a stumble in the market that brought CRON to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -34.60% of loss for the given period.

Volatility was left at 8.11%, however, over the last 30 days, the volatility rate increased by 10.81%, as shares surge +26.34% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +16.92% upper at present.

During the last 5 trading sessions, CRON fell by -2.08%, which changed the moving average for the period of 200-days by -22.44% in comparison to the 20-day moving average, which settled at $2.03. In addition, Cronos Group Inc. saw -6.89% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at CRON starting from ADLER JASON MARC, who purchase 37,500 shares at the price of $1.74 back on May 30. After this action, ADLER JASON MARC now owns 1,402,304 shares of Cronos Group Inc., valued at $65,074 using the latest closing price.

ADLER JASON MARC, the Director of Cronos Group Inc., purchase 100,000 shares at $1.80 during a trade that took place back on May 25, which means that ADLER JASON MARC is holding 1,376,054 shares at $179,650 based on the most recent closing price.

Stock Fundamentals for CRON

Current profitability levels for the company are sitting at:

  • -126.23 for the present operating margin
  • +6.47 for the gross margin

The net margin for Cronos Group Inc. stands at -183.60. The total capital return value is set at -9.30, while invested capital returns managed to touch -13.51. Equity return is now at value -12.50, with -12.00 for asset returns.

Based on Cronos Group Inc. (CRON), the company’s capital structure generated 0.34 points at debt to equity in total, while total debt to capital is 0.34. Total debt to assets is 0.32, with long-term debt to equity ratio resting at 0.22. Finally, the long-term debt to capital ratio is 0.22.

When we switch over and look at the enterprise to sales, we see a ratio of 0.49, with the company’s debt to enterprise value settled at 0.05. The receivables turnover for the company is 2.57 and the total asset turnover is 0.07. The liquidity ratio also appears to be rather interesting for investors as it stands at 14.10.


In a nutshell, Cronos Group Inc. (CRON) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Should You Invest in BP p.l.c. (BP) Now?

BP p.l.c. (NYSE: BP) has a higher price-to-earnings ratio of 5.78x compared to its average ratio, and the 36-month beta value for BP is at